Both in Pharmaceuticals
Collegium Pharmaceutical vs Alumis
Over the past year COLL returned −33.9% and ALMS returned +41.7%; their daily moves had a correlation of 0.13.
COLL −33.9% ALMS +41.7%Growth of $1, one year, split-adjusted
| Metric | COLL | ALMS |
|---|---|---|
| Price | $23.80 | $6.73 |
| Market cap | $774.8M | $871.1M |
| Today | −0.96% | −2.32% |
| 1 month | +9.0% | −6.7% |
| 6 months | −30.7% | −73.3% |
| Year to date | −48.6% | −31.0% |
| 1 year | −31.6% | +42.9% |
| Revenue growth (YoY) | +6.3% | −37.7% |
| Gross margin | 86.7% | 100.0% |
| Net margin | −7.5% | −8557.2% |
| P/E (TTM) | 16.2× | — |
| Price / sales | 1.0× | 117.7× |
| Net cash | -$962.1M | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | 38.6% | 180.2% |
| Short % of float | 18.2% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).